170 related articles for article (PubMed ID: 29973431)
1. Association of Subclinical Intrastent Thrombus Detected 9 Months After Implantation of 2nd-Generation Drug-Eluting Stent With Future Major Adverse Cardiac Events - A Coronary Angioscopic Study.
Okuno S; Ishihara T; Iida O; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Takahara M; Uematsu M; Mano T
Circ J; 2018 Aug; 82(9):2299-2304. PubMed ID: 29973431
[TBL] [Abstract][Full Text] [Related]
2. In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).
Ueda Y; Matsuo K; Nishimoto Y; Sugihara R; Hirata A; Nemoto T; Okada M; Murakami A; Kashiwase K; Kodama K
JACC Cardiovasc Interv; 2015 May; 8(6):814-821. PubMed ID: 25999104
[TBL] [Abstract][Full Text] [Related]
3. Angioscopic assessments and clinical outcomes one year after polymer-free biolimus A9-coated coronary stent implantation.
Tsujimura T; Ishihara T; Okuno S; Iida O; Kurata N; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Matsuda Y; Hata Y; Mano T
J Cardiol; 2021 May; 77(5):457-464. PubMed ID: 33121798
[TBL] [Abstract][Full Text] [Related]
4. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
[TBL] [Abstract][Full Text] [Related]
5. Impact of Neointimal Condition and Platelet Reactivity on Intrastent Thrombus at Long-Term Follow-up After 2nd- and 3rd-Generation Drug-Eluting Stent Implantation - Insights From a Coronary Angioscopy and Pharmacodynamic Study.
Matsuura T; Ueno M; Watanabe H; Yasuda M; Takase T; Nakamura T; Yamaji K; Iwanaga Y; Miyazaki S; Nakazawa G
Circ J; 2020 Nov; 84(12):2244-2252. PubMed ID: 33162462
[TBL] [Abstract][Full Text] [Related]
6. Impact of ultra-long second-generation drug-eluting stent implantation.
Honda Y; Muramatsu T; Ito Y; Sakai T; Hirano K; Yamawaki M; Araki M; Kobayashi N; Takimura H; Sakamoto Y; Mouri S; Tsutumi M; Takama T; Takafuji H; Tokuda T; Makino K
Catheter Cardiovasc Interv; 2016 Feb; 87(2):E44-53. PubMed ID: 26010548
[TBL] [Abstract][Full Text] [Related]
7. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
8. Identification of post-procedural optical coherence tomography findings associated with the 1-year vascular response evaluated by coronary angioscopy.
Higashino N; Ishihara T; Iida O; Tsujimura T; Hata Y; Toyoshima T; Nakao S; Kurata N; Mano T
Cardiovasc Interv Ther; 2023 Jan; 38(1):86-95. PubMed ID: 35917060
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Chronic Angioscopic Findings of Bare Metal Stents, 1st-Generation Drug-Eluting Stents and 2nd-Generation Drug-Eluting Stents - Multicenter Study of Intra-Coronary Angioscopy After Stent (MICASA).
Dai K; Matsuoka H; Kawakami H; Sato T; Watanabe K; Nakama Y; Ishihara M
Circ J; 2016 Aug; 80(9):1916-21. PubMed ID: 27357218
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Morphological Predictors of Intrastent Coronary Thrombus After Drug-Eluting Stent Implantation (from a Multicenter Registry).
Gao L; Lee S; Kim CJ; Minami Y; Ong DS; Soeda T; Lowe H; Choi SY; Lerman A; Lee J; Lee H; Uemura S; Yu B; Jang IK
Am J Cardiol; 2016 Feb; 117(3):369-75. PubMed ID: 26705880
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).
Prati F; Romagnoli E; Gatto L; La Manna A; Burzotta F; Limbruno U; Versaci F; Fabbiocchi F; Di Giorgio A; Marco V; Ramazzotti V; Di Vito L; Trani C; Porto I; Boi A; Tavazzi L; Mintz GS
Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965297
[TBL] [Abstract][Full Text] [Related]
13. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
15. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
16. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
17. Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients.
Shin DH; Hong SJ; Mintz GS; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Interv; 2016 Nov; 9(21):2232-2239. PubMed ID: 27744039
[TBL] [Abstract][Full Text] [Related]
18. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.
Giustino G; Baber U; Aquino M; Sartori S; Stone GW; Leon MB; Genereux P; Dangas GD; Chandrasekhar J; Kimura T; Salianski O; Stefanini GG; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; Galatius S; Von Birgelen C; Saporito R; Jeger RV; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
JACC Cardiovasc Interv; 2016 Apr; 9(7):674-84. PubMed ID: 27056305
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
